The most common perimenopausal sleep symptoms are:

• Difficulty falling asleep.
• Night-time waking (particularly with night sweats).
• Early-morning waking.
• A marked drop in subjective sleep quality.

These are often layered on top of broader perimenopausal symptoms like anxiety, mood changes, and irritability. Hachul et al. (Menopause Review, 2023) summarised the epidemiological evidence and confirmed that 40–60% of women experience clinically significant sleep disruption during the perimenopausal transition.

Vasomotor symptoms (hot flushes, night sweats) are the most well-documented mechanical driver of night-time waking, but many women experience sleep disruption even without significant vasomotor symptoms. The hormonal milieu — falling and fluctuating oestrogen and progesterone — affects sleep architecture, mood, and arousal regulation independently.

If your sleep has changed substantially in your 40s, you are not imagining it — and it is treatable. CBT-I, with adaptations for vasomotor symptoms, has strong evidence in this population.

Yes — sleep disruption is one of the most commonly reported symptoms of perimenopause, affecting up to 60% of women during this transition.

The mechanisms are multiple:

• Night sweats and hot flushes can fragment sleep directly.
• Fluctuating oestrogen and progesterone affect sleep architecture.
• Changing serotonin levels influence mood and sleep quality.
• The life stress that often coincides with midlife adds to the arousal burden.

However — and this is crucial — the insomnia that develops in perimenopause is maintained by the same conditioned arousal mechanisms as any other insomnia, which is why CBT-I is as effective in perimenopausal women as in any other group.

Several things converge in the 40s to make sleep more challenging:

• Perimenopause begins to shift hormonal profiles.
• Life reaches peak complexity — career demands, teenage children, ageing parents.
• Sleep architecture naturally changes with age — lighter, more fragmented, earlier waking.

For women, the early perimenopause period can bring night sweats that fragment sleep, and the associated anxiety about health and ageing can generate its own arousal. The combination of biological change, life stress, and accumulated worry about sleep can turn a manageable wobble into established insomnia.

The good news is that all of these are addressable.

The three stages differ in important ways for sleep:

• Perimenopause — the transitional phase before periods stop, typically lasting 4–8 years, with fluctuating hormones and the most sleep disruption.
• Menopause — technically defined as 12 months without a period.
• Postmenopause — everything after.

During perimenopause, oestrogen and progesterone fluctuate dramatically rather than simply declining — and these fluctuations are responsible for the most intense vasomotor symptoms and sleep disruption. By postmenopause, hormones reach a stable (low) state, and vasomotor symptoms typically diminish over years (though for some women they persist for a decade or more). Sleep architecture changes that occurred during perimenopause may stabilise but don't fully reverse.

For sleep, the distinction matters because perimenopause is when the most acute disruption typically occurs — but conditioned insomnia developed during this phase commonly persists into postmenopause. Treating early, during perimenopause itself, produces better outcomes than waiting.

Because hormonal changes begin years before menstrual periods stop — perimenopause typically lasts 4–8 years, with significant oestrogen and progesterone fluctuations starting in the early-to-mid 40s for most women. Sleep is often one of the earliest symptoms to change.

The SWAN study (Study of Women's Health Across the Nation; Kravitz et al., Sleep, 2008 and subsequent papers) tracked over 3,000 women through the menopausal transition and found significantly increased rates of difficulty falling and staying asleep starting in early perimenopause — often before vasomotor symptoms became prominent. Progesterone, which has a calming, GABA-modulating effect, declines earlier than oestrogen in many women, removing a natural sleep-supporting influence.

If you are in your early 40s with new or worsening sleep problems, perimenopause is worth considering even if your periods are still regular. The hormonal changes precede the obvious menstrual changes by years for many women.

Yes — first-time chronic insomnia in midlife is common during perimenopause, even in women who slept reliably well their entire lives. The combination of hormonal change, vasomotor symptoms, and life-stage stress can trigger it for the first time.

The SWAN study (Kravitz et al.) and other longitudinal cohorts consistently show a significant rise in new-onset insomnia during perimenopause, including in women with no prior sleep difficulty. The trigger is usually a sequence:

• Hormonal fluctuations disrupt sleep architecture.
• Vasomotor episodes interrupt sleep.
• The experience of poor nights generates sleep anxiety.
• Conditioned arousal sets in.

By the time the perimenopausal transition stabilises (often years later), the anxiety-driven mechanism has often become the dominant maintaining factor.

The good news: first-time perimenopausal insomnia responds well to CBT-I (Drake et al., JAMA Network Open, 2019), often dramatically. Earlier treatment usually means faster recovery.

Hot flushes and night sweats fragment sleep mechanically through the autonomic surge that accompanies them — a brief, intense rise in heart rate, skin temperature, and arousal that pulls you out of sleep, often without you fully recognising why you woke.

Freedman & Roehrs (Menopause, 2007) studied vasomotor episodes with polysomnography and found that hot flushes are associated with brief arousals and longer wake periods, particularly in the first half of the night. The mechanism appears to involve narrowed thermoregulatory zones during oestrogen withdrawal, with the brain reacting to small temperature changes as if they were larger.

Importantly, many women with insomnia during perimenopause do not show clear vasomotor-driven wakings on polysomnography — the sleep disruption has multiple causes.

For vasomotor-driven wakings specifically:

• Cooling strategies help — a cooler bedroom, layered light bedding, cooling fabrics, a fan.
• HRT addresses the underlying hormonal driver.
• CBT-I addresses the conditioned arousal that often layers on top.

For women in their 40s and 50s, night sweats are most commonly part of perimenopausal vasomotor symptoms — sudden episodes of dramatically increased core temperature followed by sweating and chills. But night sweats can also have other causes worth ruling out.

Freedman (Menopause, 2014) and subsequent work has characterised vasomotor episodes as the result of a narrowed thermoneutral zone in the hypothalamus during oestrogen withdrawal — small temperature changes trigger disproportionate sweating responses.

Other causes to be aware of:

• Certain medications (SSRIs, opioids).
• Thyroid disorders.
• Sleep apnoea.
• Infections (including TB and HIV).
• Some cancers (lymphoma especially).
• Anxiety.

If night sweats are new, severe, or accompanied by other concerning symptoms — unexplained weight loss, lumps, fever, persistent cough — please see your GP. For straightforward perimenopausal night sweats, cooling strategies plus discussion of HRT or non-hormonal options can substantially improve sleep.

Important: this information is for general education and is not medical advice. Always check with your GP or pharmacist before starting, stopping or changing any medication or making any changes to your healthcare or lifestyle.

Yes — new-onset or worsening anxiety in midlife is common during perimenopause, and the combination of anxiety and hormonal sleep disruption is one of the most significant patterns I see clinically.

Fluctuating oestrogen affects serotonin and GABA signalling, both involved in anxiety regulation. Many women experience their first significant anxiety symptoms in perimenopause — sometimes alongside, sometimes preceding, the more obvious vasomotor symptoms. Bromberger et al. (Journal of Affective Disorders, 2007 and subsequent work) found significantly elevated anxiety in perimenopausal women in the SWAN cohort, even after controlling for stress and life-stage factors.

The anxiety then often layers on top of hormonal sleep changes, creating a more entrenched pattern. If you have developed anxiety in midlife alongside sleep changes, both are likely treatable — CBT-I addresses the sleep mechanisms, and a discussion with your GP about anxiety management (talking therapy, possibly HRT, occasionally SSRIs) may be valuable.

Yes — perimenopause produces measurable changes in sleep architecture, including reduced slow-wave (deep) sleep and somewhat shortened REM, alongside increased sleep fragmentation. These changes are subtle but real.

Kravitz et al. (Sleep, 2008; SWAN study) and subsequent research have documented modest decreases in slow-wave sleep and increased arousal frequency through the menopausal transition. The mechanism likely involves declining progesterone (which supports deep sleep through GABA modulation) and the indirect effects of vasomotor episodes on sleep continuity. REM changes are more variable across studies — some women show measurable changes; others don't, despite reporting subjective sleep disruption.

This is partly why subjective sleep quality often worsens more than objective measures during perimenopause — the felt experience reflects not just architecture changes but also conditioned arousal, sleep anxiety, and the broader cognitive load of the life stage. All of these are addressable.

Yes — oestrogen affects sleep architecture, thermoregulation, mood, and serotonin signalling, all of which influence sleep quality. Falling and fluctuating oestrogen during perimenopause produces measurable effects on sleep continuity and depth.

Oestrogen helps maintain REM sleep, supports thermoregulation (preventing the temperature fluctuations that produce hot flushes), and modulates serotonin and acetylcholine — both involved in sleep regulation. Joffe et al. (JAMA Internal Medicine, 2014) demonstrated that experimentally induced oestrogen withdrawal in younger women produced measurable increases in night-time arousals, particularly in those with a prior vasomotor symptom history.

Oestrogen replacement (oral, transdermal, or vaginal in some cases) reduces vasomotor symptoms and can improve sleep continuity, particularly when symptoms are clearly hormonal in origin. If hormone replacement is being considered, discuss it with your GP — they will weigh your individual risk profile (family history, cardiovascular health, breast cancer risk). The decision is highly individual.

Important: this information is for general education and is not medical advice. Always check with your GP or pharmacist before starting, stopping or changing any medication or making any changes to your healthcare or lifestyle.

Yes — progesterone has a sedating, sleep-supporting effect via its metabolite allopregnanolone, which activates GABA-A receptors in a similar way to benzodiazepines. Falling progesterone in perimenopause removes a natural sleep facilitator.

Progesterone declines earlier and more steeply than oestrogen in many women during perimenopause, often before menstrual cycles become irregular. Caufriez et al. (Journal of Clinical Endocrinology & Metabolism, 2011) demonstrated that progesterone supplementation in postmenopausal women improved sleep continuity and reduced nocturnal awakenings, with effects mediated by the GABA system.

Bioidentical progesterone (micronised oral progesterone, e.g. Utrogestan) is sometimes prescribed for sleep in perimenopausal women, particularly those not requiring full HRT. If perimenopausal sleep disruption is significant for you, progesterone is one option worth discussing with your GP. As with all hormonal decisions, this is for your prescriber to assess in the context of your full health picture.

Important: this information is for general education and is not medical advice. Always check with your GP or pharmacist before starting, stopping or changing any medication or making any changes to your healthcare or lifestyle.

HRT may help if hot flushes and night sweats are the primary cause of your sleep disruption, and for those women it can be a genuinely useful intervention.

However, for most perimenopausal women with established insomnia, there is also a significant conditioned arousal component — the brain has learned to treat sleep as a threat, the relationship with the bed has broken down, and sleep anxiety has developed. HRT does not address any of that.

The combination of HRT (where appropriate, under your GP's guidance) and CBT-I tends to produce the best outcomes, because they address different aspects of the problem.

Important: this information is for general education and is not medical advice. Always check with your GP or pharmacist before starting, stopping or changing any medication or making any changes to your healthcare or lifestyle.

Yes — several non-hormonal medications have evidence for reducing vasomotor symptoms (and indirectly improving sleep) in women who can't or prefer not to take HRT. These are prescription decisions for your GP.

• Low-dose SSRIs and SNRIs (paroxetine, venlafaxine, escitalopram) — shown to reduce hot flushes and improve sleep continuity in randomised trials (Joffe et al., JAMA Internal Medicine, 2014, and subsequent reviews).
• Gabapentin and pregabalin — evidence for reducing night-time hot flushes specifically.
• Fezolinetant (Veozah/Veoza) — a newer selective NK3 receptor antagonist approved in 2023, targeting vasomotor symptoms directly with a different mechanism and growing real-world data.

Each has its own side-effect and interaction profile. Any medication for perimenopausal symptoms is a GP decision based on your full health picture.

Important: this information is for general education and is not medical advice. Always check with your GP or pharmacist before starting, stopping or changing any medication or making any changes to your healthcare or lifestyle.

The evidence for herbal menopause remedies (black cohosh, red clover, soy isoflavones) is mixed and generally weak for sleep specifically, and several carry meaningful safety considerations.

• Black cohosh — Leach & Moore (Cochrane Database, 2012; updated since) found inconsistent effects on vasomotor symptoms and no convincing evidence for direct sleep benefit. Rare reports of liver toxicity exist.
• Soy isoflavones — modest reductions in hot flushes in some trials but not others.
• Red clover — minimal evidence.

More importantly, herbal menopause products are not strictly regulated; product quality varies enormously, and several carry interactions or contraindications. Phytoestrogens may not be appropriate in women with hormone-sensitive conditions.

Important: this information is for general education and is not medical advice. Always check with your GP or pharmacist before starting, stopping or changing any medication or making any changes to your healthcare or lifestyle.

The highest-impact lifestyle adjustments combine several elements:

• Cooling strategies — a cooler bedroom (around 16–18°C), layered light bedding, cooling pillows or fans, breathable fabrics.
• Consistent wake time — anchors the circadian rhythm at a stage when it tends to flatten.
• Daytime physical activity — meta-analyses of exercise and menopausal sleep (Kredlow et al., Journal of Behavioral Medicine, 2015) show consistent modest improvements with regular moderate activity earlier in the day.
• Reduced alcohol — even small amounts at this life stage often produce worse sleep fragmentation than they did premenopause.
• Protecting the bed — avoiding extended time in bed during bad-sleep weeks guards against developing conditioned arousal.

None of these is a 'cure' on its own, but combined they can meaningfully improve the perimenopausal sleep picture. If they aren't enough, CBT-I and possibly HRT or non-hormonal options become the next step.

Absolutely — and I say this from personal experience as well as clinical evidence. I am approaching 50 and navigating perimenopause myself, and I sleep 8.5 to 9.5 hours a night regularly.

CBT-I works exactly as well for perimenopausal women as for anyone else, because the mechanisms it addresses — conditioned arousal, sleep drive, cognitive hypervigilance — are the same regardless of hormonal status.

If anything, having an evidence-based framework for understanding and managing sleep is even more valuable during a period of significant hormonal change, because it gives you tools that will serve you wherever in the perimenopause transition you are.

Often partially, but not always automatically. The hormonal volatility of perimenopause typically stabilises after menopause, which removes one driver of sleep disruption — but conditioned arousal and sleep anxiety that developed during the transition tend to persist unless addressed.

The SWAN study (Kravitz et al., Sleep, 2008 and follow-up papers) tracked women through and beyond the menopausal transition and found that vasomotor symptoms and acute sleep disturbance tend to peak in late perimenopause and early postmenopause, gradually improving over subsequent years. However, women who developed chronic insomnia during the transition often retain it without specific treatment — the underlying mechanism shifts from hormonal to behavioural/cognitive.

The good news: insomnia that began during perimenopause responds to the same evidence-based treatment (CBT-I) as insomnia from any other cause. Waiting for menopause to 'fix it' rarely works as well as addressing the conditioned arousal directly.

Probably not — the common belief that older adults need less sleep is largely a myth. What appears to be reduced sleep need is more accurately a reduced ability to sustain consolidated sleep, often combined with shifted circadian timing.

The National Sleep Foundation expert panel (Hirshkowitz et al., Sleep Health, 2015) recommends 7–8 hours for older adults (65+), slightly less than the 7–9 hours for younger adults but not dramatically so. Sleep need declines very modestly with age — by perhaps 30–60 minutes from young adulthood to old age. What does change is sleep architecture (less deep sleep, more wakings), making it harder to achieve consolidated sleep even when the underlying need is similar.

If you are an older adult getting 6 hours and feeling unrested, you may not have 'a smaller sleep need' — you may have age-related sleep fragmentation that is treatable. Worth investigating rather than accepting as inevitable.